13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001012975-24-000328
Total Value
$795.8M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,146,979 | $624.2M | 78.43% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $135.3M | 17.00% |
| 3 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $9.0M | 1.14% |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $7.0M | 0.88% |
| 5 | ALECTOR INC | ALEC | 1,307,858 | $5.9M | 0.75% |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $4.3M | 0.53% |
| 7 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $4.0M | 0.50% |
| 8 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $3.1M | 0.40% |
| 9 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $2.0M | 0.25% |
| 10 | SURROZEN INC | SRZNW | 87,696 | $960,271 | 0.12% |
| 11 | SURROZEN INC | SRZNW | 170,833 | $2,836 | 0.00% |